Kentucky Legal News Articles & Interviews

Pittsburgh, PA: Viola Chapman began taking Onglyza and Kombiglyze XR (Saxagliptin) to treat her type 2 diabetes in February 2015. By December, as her Onglyza lawsuit claims, those drugs had caused heart failure, congestive heart failure and cardiovascular injury.

Cleveland, OH:Across the U.S., city and county newspapers looking back on 2017 say the top news story was the opioid crisis. And opioid litigation already looks like it will dominate legal news in 2018.

Los Angeles, CA: When Janumet (sitagliptin and metformin combined) was approved by the US Food and Drug Administration (FDA) in 2007, the type 2 diabetes drug was within five years of achieving sales of $1.7 Billion. That year, when Janumet hit blockbuster status by 2012, the parent drug of Janumet – Januvia – earned $4 Billion for manufacturer Merck & Co. Januvia has been associated with Januvia side effects, and has resulted in Januvia cancer lawsuits.

Frankfort, KY: An IVC filter lawsuit that was originally tossed out by a trial court due to the absence of an expert witness has survived after all, following a ruling by the Kentucky Supreme Court that the trial court judge was too hasty in dismissing the lawsuit.

Chicago, Ill Lawyers representing Dr. David Dao, the 69-year-old passenger who was forcibly removed from a United Airlines flight, have filed an emergency request with a court in Chicago asking the airline to preserve all video, cockpit recordings, surveillance video, passenger and crew lists and other evidence related to the incident.

Nashville, TN:When Sara had an IVC Filter implanted 20 years ago, nobody told her that it would eventually need to be removed. “Now that I’m aware of so many IVC filter lawsuits I don’t know if this filter is supposed to be permanent or not, but it has got me worried,” says Sara.

Owensboro, KY: It’s a situation that is the closest one might come to a crystal ball: the sentencing of a salvage company owner who allowed the demolition of an asbestos-laden tire plant without protecting his workers from asbestos fibers. As it takes asbestos mesothelioma some 30 years to emerge in most cases, it is not beyond the realm of possibility that new asbestos claims may well be stemming from this incident three decades from now.

Bowling Green, KY: As plaintiffs continue to wait for bellwether lawsuits to get going next year, IVC filter lawsuits continue to filter in. The most recent was filed just a couple of weeks ago, identified as Burroughs v. Cook Medical, Inc., Case No. 1:16-cv-02524, filed September 22 in US District Court, Southern District of Indiana. Additional lawsuits continue to be filed against C.R. Bard, another major supplier of IVC filters and a manufacturer caught in the crosshairs of disgruntled plaintiffs alleging negligence, and a defective product.

Washington, DC: It’s not that difficult to understand why Johnson & Johnson, the makers of anti-psychotic drug Risperdal (risperidone), would take lawsuits and criticism in stride given the revenues generated by the blockbuster drug: reported by Bloomberg to be $24.2 billion in worldwide sales from 2003 through 2010. In that sense, any corresponding Risperdal lawsuits over Risperdal side effects such as the growth of male breasts, or risk-taking activity beyond the perimeters of regulatory boundaries, could be seen as simply a cost of doing business.

Albany, NY: The manufacturers of Risperdal have been facing the financial music in Risperdal lawsuits of late, with a $15.5 million settlement with the State of Kentucky over allegations the Janssen Pharmaceuticals unit of Johnson & Johnson failed to disclose risks, and marketed the drug off-label. That was soon followed by the $70 million dollar Risperdal side effects lawsuit win by plaintiff Andrew Yount, who alleged Risperdal caused him to grow male breasts.